Literature DB >> 25750060

The complexity of dialytic therapy in hyperammonemic neonates.

Timothy E Bunchman1.   

Abstract

The utilization of renal replacement therapy (RRT) in the setting of hyperammonia is a rare and complicated occurrence. Data demonstrate that the quicker the ammonia level is normalized, the better the neurological outcome. The optimal form of RRT is often decided by local practice. The recent work by Picca and colleagues details a larger series of children who underwent RRT for hyperammonia and adds some credence to the use of peritoneal dialysis (PD) in this population. While these authors conclude that PD is not optimal, they do note that the use of PD may be an option when other forms of RRT are not available. The results reinforce the general maxim that you should continue to do that which you do well and often, which in this context refers to continuing to use your form of RRT until alternative modalities are available.

Entities:  

Mesh:

Year:  2015        PMID: 25750060     DOI: 10.1007/s00467-014-2998-x

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  4 in total

1.  Clearance of amino acids by hemodialysis in argininosuccinate synthetase deficiency.

Authors:  Kevin D McBryde; Timothy L Kudelka; David B Kershaw; Patrick D Brophy; John J Gardner; William E Smoyer
Journal:  J Pediatr       Date:  2004-04       Impact factor: 4.406

2.  Phenylacetate and benzoate clearance in a hyperammonemic infant on sequential hemodialysis and hemofiltration.

Authors:  Timothy E Bunchman; Gina-Marie Barletta; John W Winters; John J Gardner; Teri L Crumb; Kevin D McBryde
Journal:  Pediatr Nephrol       Date:  2007-02-03       Impact factor: 3.714

3.  Short-term survival of hyperammonemic neonates treated with dialysis.

Authors:  Stefano Picca; Carlo Dionisi-Vici; Andrea Bartuli; Tommaso De Palo; Francesco Papadia; Giovanni Montini; Marco Materassi; Maria Alice Donati; Enrico Verrina; Maria Cristina Schiaffino; Carmine Pecoraro; Emilia Iaccarino; Enrico Vidal; Alberto Burlina; Francesco Emma
Journal:  Pediatr Nephrol       Date:  2014-09-04       Impact factor: 3.714

4.  Renal replacement therapy in the treatment of confirmed or suspected inborn errors of metabolism.

Authors:  Kevin D McBryde; David B Kershaw; Timothy E Bunchman; Norma J Maxvold; Theresa A Mottes; Timothy L Kudelka; Patrick D Brophy
Journal:  J Pediatr       Date:  2006-06       Impact factor: 4.406

  4 in total
  2 in total

Review 1.  The Role of RRT in Hyperammonemic Patients.

Authors:  Shruti Gupta; Andrew Z Fenves; Robert Hootkins
Journal:  Clin J Am Soc Nephrol       Date:  2016-05-19       Impact factor: 8.237

2.  A surviving 24-month-old patient with neonatal-onset carnitine palmitoyltransferase II deficiency.

Authors:  Naohiro Ikeda; Shinsuke Maruyama; Kanna Nakano; Ryo Imakiire; Yumiko Ninomiya; Shunji Seki; Kosuke Yanagimoto; Yasuyuki Kakihana; Keiichi Hara; Go Tajima; Yasuhiro Okamoto; Yoshifumi Kawano
Journal:  Mol Genet Metab Rep       Date:  2017-05-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.